Eli Lilly and Novo Nordisk report GLP-1 drugs slow aging, per molecular 'aging clock' readouts

Eli Lilly and Novo Nordisk say patients taking their GLP-1 drugs age less quickly, according to readouts from molecular 'aging clocks.' The findings add to speculation among scientists that GLP-1 drugs act on basic causes of aging and may be a true longevity treatment.

Detected & updated continuously · Source: Nebula